Abbott opens new manufacturing facility for diabetes business in Ireland
The Kilkenny, Ireland facility will focus on the global manufacturing of sensors for Abbott’s CGM diabetes devices.
19 November 2024
19 November 2024
The Kilkenny, Ireland facility will focus on the global manufacturing of sensors for Abbott’s CGM diabetes devices.
The CE mark for the assay follows earlier pre-authorisation in Austria and Germany.
AI has a huge role to play in realising more sophisticated forms of automation in robotic surgery.
Larger GP practices, community hospitals and mobile vans could offer the test by October 2025.
The inconsistencies within the campaign have made it difficult to say exactly what a Trump victory means for abortion and reproductive health in general.
The trial's findings show that the Amplatzer Amulet achieved superior LAA closure rates of 89.2%.
The test has shown an 86% early-stage sensitivity and 88% specificity, outperforming traditional testing methods.
The software is designed to improve the accuracy of detecting morphological abnormalities during foetal heart ultrasound exams.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.